This inventor holds 1 USPTO granted patent. Top assignee: Uutech Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovations of Finbarr Paul O'Harte
Introduction
Finbarr Paul O'Harte, an accomplished inventor based in Ballymoney, Great Britain, has made significant strides in the field of diabetes treatment. With a focus on peptide research, his work aims to enhance insulin release, providing new avenues for diabetes management.
Latest Patents
Finbarr Paul O'Harte holds a patent for "Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes." This innovative invention introduces peptides that stimulate insulin secretion. The peptides, derived from GIP 1-42, are modified to improve their efficacy and resistance to degradation, contributing to more effective diabetes treatment modalities.
Career Highlights
Finbarr is affiliated with Uutech Limited, a company renowned for its commitment to advancing medical research. His dedication to the field is exemplified by his focus on the biochemistry of peptide analogues, aiming to revolutionize how diabetes is treated.
Collaborations
Working alongside his colleague, Peter Raymond Flatt, Finbarr has been part of a dynamic team that fosters innovation and research excellence. Their collaboration highlights the importance of teamwork in propelling advancements in medical science.
Conclusion
In conclusion, Finbarr Paul O'Harte exemplifies the role of inventors in transforming healthcare through innovative research and patentable inventions. His contributions, particularly in diabetes treatment, demonstrate the potential for peptides in medical applications, marking a significant milestone in the ongoing battle against diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile